Genetic susceptibility, residential radon, and lung cancer in a radon prone area

Journal of Thoracic Oncology

Volumn 9, Issue 8, 2014, Pages 1073-1080

  Ruano Ravina, Alberto ^a,b   Pereyra, Marco F ^c   Castro, Marta Tojo ^d,e   Pérez Ríos, Mónica ^a,b   Abal Arca, José ^f   Barros Dios, Juan Miguel ^a,b,g  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Clinic University Hospital   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Ourense Hospital Complex   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Genetic susceptibility; Lung neoplasms; Residential radon

Indexed keywords

RADON; AIR POLLUTANT; EPHX1 PROTEIN, HUMAN; EPOXIDE HYDROLASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE MU 2; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GSTM1 GENE; GSTT1 GENE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RESIDENTIAL AREA; SMOKING; TUMOR GENE; ADVERSE EFFECTS; AIR POLLUTANT; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INDOOR AIR POLLUTION; LUNG NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICITY;

AGED; AIR POLLUTANTS, RADIOACTIVE; AIR POLLUTION, INDOOR; CASE-CONTROL STUDIES; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION DOSAGE; RADON; RISK FACTORS; SEQUENCE DELETION; SMOKING;

EID: 84905911800     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000205     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a populationbased study. Lancet Oncol 2014;15:23-34.
3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-1403.
4. World Health Organization. WHO Handbook on Indoor Radon: A Public Health Perspective. Geneva, Switzerland: World Health Organization; 2009.
5. EPA's Radon Program Home Page [Internet]. Available at: http://www. epa.gov/radon/. Accessed July 11, 2013.
6. Narayanan PK, Goodwin EH, Lehnert BE. Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res 1997;57:3963-3971.
7. Little JB. Radiation carcinogenesis. Carcinogenesis 2000;21:397-404.
8. Tripodis N, Hart AA, Fijneman RJ, Demant P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst 2001;93:1484-1491.
9. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology 2006;17:89-99.
10. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-743.
11. Garte S, Gaspari L, Alexandrie A-K, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239-1248.
12. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature- based systematic HuGE review and meta-analysis. Am J Epidemiol 2008;167:759-774.
13. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2006;164:1027-1042.
14. Bonner MR, Bennett WP, Xiong W, et al. Radon, secondhand smoke, glutathione- S-transferase M1 and lung cancer among women. Int J Cancer. 2006;119:1462-1467.
15. Barros-Dios JM, Ruano-Ravina A, Gastelu-Iturri J, Figueiras A. Factors underlying residential radon concentration: Results from Galicia, Spain. Environmen Res 2007;103:185-190.
16. Barros-Dios JM, Barreiro MA, Ruano-Ravina A, Figueiras A. Exposure to residential radon and lung cancer in Spain: a population-based casecontrol study. Am J Epidemiol 2002;156:548-555.
17. Barros-Dios JM, Ruano-Ravina A, Pérez-Ríos M, Castro-Bernárdez M, Abal-Arca J, Tojo-Castro M. Residential radon exposure, histologic types, and lung cancer risk. A case-control study in Galicia, Spain. Cancer Epidemiol Biomarkers Prev 2012;21:951-958.
18. Gutierrez-Villanueva JL, Sainz-Fernández C, Fuente-Merino I, Sáez- Vergara JC, Correa-Garcés E, Quindos-Poncela LS. Intercomparison exercise on external gamma dose rate under field conditions at the laboratory of natural radiation (Saelices el Chico, Spain). Radiat Prot Dosimetry 2013;155:459-466.
19. Khedhaier A, Remadi S, Corbex M, et al. Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma. Br J Cancer. 2003;89:1502-1507.
20. Buetow KH, Edmonson M, MacDonald R, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA. 2001;98:581-584.
21. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-456.
22. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
23. Taioli E, Zocchetti C, Garte S. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 1998;106:67-70.
24. Vineis P, Alavanja M, Garte S. Dose-response relationship in tobaccorelated cancers of bladder and lung: a biochemical interpretation. Int J Cancer. 2004;108:2-7.
25. Sun J, Chen Y, Li M, Ge Z. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med 1998;24:586-593.
26. Patel JM. Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol Ther 1990;47:137-146.
27. Ambrosone CB, Sweeney C, Coles BF, et al. Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Res. 2001;61:7130-7135.
28. Goto I, Yoneda S, Yamamoto M, Kawajiri K. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer Res 1996;56:3725-3730.
29. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005;26:395-401.
30. Marcon F, Andreoli C, Rossi S, Verdina A, Galati R, Crebelli R. Assessment of individual sensitivity to ionizing radiation and DNA repair efficiency in a healthy population. Mutat Res 2003;541:1-8.
31. Sal'nikova LE, Chumachenko AG, Vesnina IN, et al. The relationship between genotypes and frequencies of chromosome aberrations in human lymphocytes under irradiation in vivo and in vitro. Radiats Biol Radioecol 2010;50:340-344.
32. Sakly A, Gaspar JF, Kerkeni E, et al. Genotoxic damage in hospital workers exposed to ionizing radiation and metabolic gene polymorphisms. J Toxicol Environ Health A 2012;75:934-946.
33. Ruano-Ravina A, Figueiras A, Loidi L, Barros-Dios JM. GSTM1 and GSTT1 polymorphisms, tobacco and risk of lung cancer: a case-control study from Galicia, Spain. Anticancer Res 2003;23:4333-4337.